The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need.

Dionne, Pierre-Alexandre; Ali, Farzad; Grobler, Mendel

Dionne, Pierre-Alexandre; Ali, Farzad; Grobler, Mendel.

Afiliação

Dionne PA; Pfizer Canada Inc., Kirkland, Canada and Department of Community Health Services, University of Sherbrooke, Longueuil, Canada.
Ali F; Pfizer Canada Inc., Kirkland, Canada.
Grobler M; Pfizer Australia Inc., West Ryde, Australia.

J Health Econ Outcomes Res ; 3(1): 13-23, 2015.

Article em En | MEDLINE | ID: mdl-34430665

Palavras-chave

cost-effectiveness analysis; drug price regulation; health technology assessment; pharmaceutical innovation; unmet medical needs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google